PDCD1 and neoplasm: The blockade of the programmed cell death 1 (PD-1) or of its ligand (PD-L1) may activate T cell stimulatory signaling, thereby enhancing antitumor T cell cytotoxicity and promoting tumor destruction [42,43,44,45,46] (Figure 5).